Literature DB >> 15596298

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

Elina Azenshtein1, Tsipi Meshel, Sima Shina, Nely Barak, Iafa Keydar, Adit Ben-Baruch.   

Abstract

The regulation of secretion of the angiogenic factors CXCL8 and Vascular Endothelial Growth Factors (VEGF) was determined in breast tumor cells and in monocytic cells (as host cells that contribute to breast cancer). CXCL8 secretion, and partly the secretion of VEGF, were up-regulated in monocytic cells, but not in breast tumor cells, by the CC chemokines CCL5 and CCL2. EGF potently up-regulated CXCL8 secretion by breast tumor cells, and its effect was promoted by a consecutive treatment of the cells by estrogen and progesterone. These findings provide evidence for a complex set of pro-malignancy factors that may control the expression of angiogenic mediators at breast tumor sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596298     DOI: 10.1016/j.canlet.2004.05.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools.

Authors:  Nese Unver
Journal:  Med Oncol       Date:  2021-05-13       Impact factor: 3.064

2.  Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells.

Authors:  A Loboda; A Jazwa; B Wegiel; A Jozkowicz; J Dulak
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-09-30       Impact factor: 1.770

3.  Interleukin 8 in progression of hormone-dependent early breast cancer.

Authors:  Jelena Milovanovic; Natasa Todorovic-Rakovic; Tijana Vujasinovic; Zaki Abu Rabi
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

Review 4.  Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.

Authors:  Anahita Tavakoli; Mohammad Saeed Kahrizi; Kimia Safa; Reza ArefNezhad; Fatemeh Rezaei-Tazangi
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

Review 5.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer.

Authors:  Xiao-Dong Xie; Shu-Xian Qu; Zhao-Zhe Liu; Fang Zhang; Zhen-Dong Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-30       Impact factor: 4.553

Review 7.  Interleukin-8 in breast cancer progression.

Authors:  Nataša Todorović-Raković; Jelena Milovanović
Journal:  J Interferon Cytokine Res       Date:  2013-05-22       Impact factor: 2.607

Review 8.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

Review 9.  An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.

Authors:  Amaresh Mishra; Kamrul Hassan Suman; Nisha Nair; Jaseela Majeed; Vishwas Tripathi
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

10.  Imagable 4T1 model for the study of late stage breast cancer.

Authors:  Kai Tao; Min Fang; Joseph Alroy; G Gary Sahagian
Journal:  BMC Cancer       Date:  2008-08-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.